419 related articles for article (PubMed ID: 18068383)
41. Midazolam attenuates the antinociception induced by d-serine or morphine at the supraspinal level in rats.
Ito K; Yoshikawa M; Maeda M; Jin XL; Takahashi S; Matsuda M; Tamaki R; Kobayashi H; Suzuki T; Hashimoto A
Eur J Pharmacol; 2008 May; 586(1-3):139-44. PubMed ID: 18384770
[TBL] [Abstract][Full Text] [Related]
42. Analgesic effects of morphine and loperamide in the rat formalin test: interactions with NMDA receptor antagonists.
Sevostianova N; Danysz W; Bespalov AY
Eur J Pharmacol; 2005 Nov; 525(1-3):83-90. PubMed ID: 16297905
[TBL] [Abstract][Full Text] [Related]
43. Peripheral interaction of opioid and NMDA receptors in inflammatory pain in rats.
Tandon OP; Mehta AK; Halder S; Khanna N; Sharma KK
Indian J Physiol Pharmacol; 2010; 54(1):21-31. PubMed ID: 21046916
[TBL] [Abstract][Full Text] [Related]
44. A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro.
Lazarczyk M; Matyja E; Lipkowski AW
Peptides; 2010 Aug; 31(8):1606-12. PubMed ID: 20580757
[TBL] [Abstract][Full Text] [Related]
45. Ketamine in cancer pain: an update.
Mercadante S
Palliat Med; 1996 Jul; 10(3):225-30. PubMed ID: 8817593
[TBL] [Abstract][Full Text] [Related]
46. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
[TBL] [Abstract][Full Text] [Related]
47. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
Kolesnikov Y; Pasternak GW
J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
[TBL] [Abstract][Full Text] [Related]
48. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
Lutfy K; Doan P; Weber E
Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
[TBL] [Abstract][Full Text] [Related]
49. Tolerance to non-opioid analgesics in PAG involves unresponsiveness of medullary pain-modulating neurons in male rats.
Tortorici V; Aponte Y; Acevedo H; Nogueira L; Vanegas H
Eur J Neurosci; 2009 Mar; 29(6):1188-96. PubMed ID: 19302154
[TBL] [Abstract][Full Text] [Related]
50. The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats.
Joó G; Horvath G; Klimscha W; Kekesi G; Dobos I; Szikszay M; Benedek G
Anesthesiology; 2000 Jul; 93(1):231-41. PubMed ID: 10861167
[TBL] [Abstract][Full Text] [Related]
51. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
[TBL] [Abstract][Full Text] [Related]
52. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists.
McNaull B; Trang T; Sutak M; Jhamandas K
Eur J Pharmacol; 2007 Apr; 560(2-3):132-41. PubMed ID: 17307158
[TBL] [Abstract][Full Text] [Related]
54. Ketamine and lornoxicam for preventing a fentanyl-induced increase in postoperative morphine requirement.
Xuerong Y; Yuguang H; Xia J; Hailan W
Anesth Analg; 2008 Dec; 107(6):2032-7. PubMed ID: 19020155
[TBL] [Abstract][Full Text] [Related]
55. Interaction between morphine and norketamine enantiomers in rodent models of nociception.
Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
Pharmacol Biochem Behav; 2008 Oct; 90(4):769-77. PubMed ID: 18582492
[TBL] [Abstract][Full Text] [Related]
56. Antinociceptive effects and synergistic interaction with morphine of intrathecal metabotropic glutamate receptor 2/3 antagonist in the formalin test of rats.
Yoon MH; Choi Jl; Bae HB; Kim SJ; Chung ST; Jeong SW; Chung SS; Yoo KY; Jeong CY
Neurosci Lett; 2006 Feb; 394(3):222-6. PubMed ID: 16293369
[TBL] [Abstract][Full Text] [Related]
57. Brain and spinal cord distribution of biphalin: correlation with opioid receptor density and mechanism of CNS entry.
Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
J Neurochem; 1997 Sep; 69(3):1236-45. PubMed ID: 9282948
[TBL] [Abstract][Full Text] [Related]
58. Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management.
Suzuki M
Curr Opin Anaesthesiol; 2009 Oct; 22(5):618-22. PubMed ID: 19535974
[TBL] [Abstract][Full Text] [Related]
59. Antagonism of stimulation-produced analgesia by naloxone and N-methyl-D-aspartate: role of opioid and N-methyl-D-aspartate receptors.
Mehta AK; Halder S; Khanna N; Tandon OP; Sharma KK
Hum Exp Toxicol; 2012 Jan; 31(1):51-6. PubMed ID: 21803783
[TBL] [Abstract][Full Text] [Related]
60. Influence of tiagabine on the antinociceptive action of morphine, metamizole and indomethacin in mice.
Pakulska W
Acta Pol Pharm; 2007; 64(3):263-70. PubMed ID: 17695150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
